Vaccination with yeast-expressed cottontail rabbit papillomavirus (CRPV) virus-like particles protects rabbits from CRPV-induced papilloma formation

Vaccine

Volumn 13, Issue 16, 1995, Pages 1509-1514

  Jansen, Kathrin U ^a   Rosolowsky, Mark ^a   Schultz, Loren D ^a   Markus, Henry Z ^a   Cook, James C ^a   Donnelly, John J ^a   Martinez, Douglas ^a   Ellis, Ronald W ^a   Shaw, Alan R ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Cottontail rabbit papillomavirus; CRPV; subunit vaccine; virus like particles

Indexed keywords

ALUMINUM; HEPATITIS B VACCINE; IMMUNOLOGICAL ADJUVANT; RECOMBINANT VACCINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; INTRAMUSCULAR DRUG ADMINISTRATION; NONHUMAN; PAPILLOMA; PRIORITY JOURNAL; RABBIT; SACCHAROMYCES CEREVISIAE; VACCINATION; WART VIRUS;

ANIMAL; ANTIBODIES, VIRAL; BASE SEQUENCE; CAPSID; FEMALE; MICE; MICE, NUDE; MOLECULAR SEQUENCE DATA; PAPILLOMA; PAPILLOMAVIRUS, COTTONTAIL RABBIT; PAPOVAVIRIDAE INFECTIONS; RABBITS; SACCHAROMYCES CEREVISIAE; TUMOR VIRUS INFECTIONS; VIRAL VACCINES; VIRION;

EID: 0028845930     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0264-410X(95)00103-8     Document Type: Article

References (28)

1. Heterogeneity of the human papillomavirus group
2. Papillomavirus in anogenital cancer the dilemma of epidemiologic approaches
3. Human papillomavirus types 6 and 11 DNA sequences in genital and laryngeal papillomas and in some cervical cancers
4. Epidemiology of genital human papillomavirus infection
5. Papillomaviruses
6. Laboratory production in vivo of infectious human papillomavirus type 11
7. Morphological transformation in vivo of human uterine cervix with papillomavirus from condylomata acuminata
8. The open reading frame L2 of cottontail rabbit papillomavirus contains antibody-inducing neutralizing epitopes
9. Studies on vaccination against papillomaviruses: prophylactic and therapeutic vaccination with recombinant structural proteins
10. Effective vaccination against papilloma development by immunization with L1 or L2 structural protein of cottontail rabbit papillomavirus
11. Prophylactic and therapeutic vaccination against a mucosal papillomavirus
12. Vaccination against papillomavirus
13. Expression of vaccinia recombinant HPV16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles
14. Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic
15. Selfassembly of human papillomavirus type 1 capsids by expression of the L1 protein alone or by coexpression of the L1 and L2 capsid proteins
16. Expression of human papillomavirus type 11 L1 protein in insect cells: in vivo and in vitro assembly of viruslike particles
17. Assembled baculovirus-expressed human papillomavirus type 11 L1 capsid protein virus-like particles are recognized by neutralizing monoclonal antibodies and induce high titres of neutralizing antibodies
18. Genetic analysis of CRPV pathogenesis: the L1 open reading frame is dispensable for cellular transformation but is required for papilloma formation
19. The primary structure of the Saccharomyces cerevisiae gene for alcohol dehydrogenase
20. Transformation of yeast by a replicating hybrid plasmid
21. The presence of a defective LEU2 gene on 2 μ DNA recombinant plasmids of Saccharomyces cerevisiae is responsible for curing and high copy number
22. Circular DNA plasmids of yeasts
23. Antibody-mediated neutralization in vivo of infectious papillomaviruses
24. Hepatitis B vaccines: blueprints for vaccines of the future
25. Summary of clinical findings on Engenerix-B, a genetically engineered yeast derived hepatitis B vaccine
26. Scope and design of hepatitis B vaccine clinical trials